BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R, Houshmandfar S, Tahmaseby Gandomkari S, Khodadadi A. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacol Immunotoxicol 2021;43:247-58. [PMID: 34015982 DOI: 10.1080/08923973.2021.1925293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Jia H, Qi X, Fu L, Wu H, Shang J, Qu M, Yang C, Wang J. NLRP3 inflammasome inhibitor ameliorates ischemic stroke by reprogramming the phenotype of microglia/macrophage in a murine model of distal middle cerebral artery occlusion. Neuropathology. [DOI: 10.1111/neup.12802] [Reference Citation Analysis]
2 Saeedi-boroujeni A, Nashibi R, Ghadiri AA, Nakajima M, Salmanzadeh S, Mahmoudian-sani M, Hanafi MG, Sharhani A, Khodadadi A. Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Palma G, Sorice GP, Genchi VA, Giordano F, Caccioppoli C, D’oria R, Marrano N, Biondi G, Giorgino F, Perrini S. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. IJMS 2022;23:7349. [DOI: 10.3390/ijms23137349] [Reference Citation Analysis]
4 Farouk AF, Shafqat A, Shafqat S, Kashir J, Alkattan K, Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, Medical College, Aga Khan University, Karachi, Pakistan, Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. . AIMSMOLES 2021;8:275-90. [DOI: 10.3934/molsci.2021021] [Reference Citation Analysis]
5 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
7 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
8 Mahnam K, Ghobadi Z. Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study. J Biomol Struct Dyn 2021;:1-21. [PMID: 34514953 DOI: 10.1080/07391102.2021.1973910] [Reference Citation Analysis]